Literature DB >> 3142252

Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations.

L A Perkocha1, G M Rodgers.   

Abstract

Hematologic abnormalities are common in patients with HIV infection. This review will focus on HIV-associated cytopenias and coagulation abnormalities. Their occurrence, laboratory evaluation, and clinical significance and the mechanisms underlying their development are discussed. Therapeutic modalities are presented, with an emphasis on treatment strategies for HIV-associated thrombocytopenia.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3142252     DOI： 10.1002/ajh.2830290207

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  16 in total

1.  Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study.

Authors:  José A Mata-Marín; Jesús E Gaytán-Martínez; Rosa E Martínez-Martínez; Carla I Arroyo-Anduiza; José L Fuentes-Allen; Moisés Casarrubias-Ramirez
Journal:  BMC Res Notes       Date:  2010-08-20

Review 2.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo.

Authors:  M Kitagawa; A A Lackner; D J Martfeld; M B Gardner; S Dandekar
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

4.  In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus.

Authors:  H N Steinberg; C S Crumpacker; P A Chatis
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.

Authors:  N C Pedersen; M Torten; B Rideout; E Sparger; T Tonachini; P A Luciw; C Ackley; N Levy; J Yamamoto
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  Early bone marrow hematopoietic defect in simian/human immunodeficiency virus C2/1-infected macaques and relevance to advance of disease.

Authors:  Kenji Yamakami; Mitsuo Honda; Masami Takei; Yasushi Ami; Noboru Kitamura; Susumu Nishinarita; Shigemasa Sawada; Takashi Horie
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus.

Authors:  G A Dean; P M Groshek; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

Review 8.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

9.  Autoantibodies against peripheral blood cells appear early in HIV infection and their prevalence increases with disease progression.

Authors:  R J Klaassen; J W Mulder; A B Vlekke; J K Eeftinck Schattenkerk; H M Weigel; J M Lange; A E von dem Borne
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

10.  Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients.

Authors:  Iván Palomo; Marcelo Alarcón; Cecilia Sepulveda; Jaime Pereira; Ricardo Espinola; Silvia Pierangeli
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.